Essais liés2clinical trials
VilleChicoutimilocalisation
PaysCanadalocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06185764

Ouvrir le site du centre

Essais cliniques associés

2
MoléculeIndication / populationPhaseNCTTitreStatut
Pitolisant Oral Tablet Myopathies Phase 2 NCT04886518 Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 COMPLETED
VX-670 Myopathies Phase 1/2 NCT06185764 Galileo — A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1) ACTIVE_NOT_RECRUITING